The osteogenic potential of the marine-derived multi-mineral formula aquamin is enhanced by the presence of vitamin D. by Widaa, Amro et al.
Royal College of Surgeons in Ireland
e-publications@RCSI
Anatomy Articles Department of Anatomy
1-5-2014
The osteogenic potential of the marine-derived
multi-mineral formula aquamin is enhanced by the
presence of vitamin D.
Amro Widaa
Royal College of Surgeons in Ireland
Orlaith Brennan
Royal College of Surgeons in Ireland, obrennan1@rcsi.ie
D M. O'Gorman
Marigot Ltd., Strand Farm, Carrigaline, Cork, Ireland
Fergal J. O'Brien
Royal College of Surgeons in Ireland, fjobrien@rcsi.ie
This Article is brought to you for free and open access by the Department
of Anatomy at e-publications@RCSI. It has been accepted for inclusion in
Anatomy Articles by an authorized administrator of e-publications@RCSI.
For more information, please contact epubs@rcsi.ie.
Citation
Widaa A, Brennan O, O'Gorman DM, O'Brien FJ. The osteogenic potential of the marine-derived multi-mineral formula aquamin is
enhanced by the presence of vitamin D. Phytotherapy Research. 2014 May;28(5):678-84. doi: 10.1002/ptr.5038.
— Use Licence —
Attribution-Non-Commercial-ShareAlike 1.0
You are free:
• to copy, distribute, display, and perform the work.
• to make derivative works.
Under the following conditions:
• Attribution — You must give the original author credit.
• Non-Commercial — You may not use this work for commercial purposes.
• Share Alike — If you alter, transform, or build upon this work, you may distribute the resulting work only
under a licence identical to this one.
For any reuse or distribution, you must make clear to others the licence terms of this work. Any of these
conditions can be waived if you get permission from the author.
Your fair use and other rights are in no way affected by the above.
This work is licenced under the Creative Commons Attribution-Non-Commercial-ShareAlike License. To
view a copy of this licence, visit:
URL (human-readable summary):
• http://creativecommons.org/licenses/by-nc-sa/1.0/
URL (legal code):
• http://creativecommons.org/worldwide/uk/translated-license
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/anatart/64
For Peer Review
 
 
 
 
 
The osteogenic potential of the marine-derived multi-
mineral formula Aquamin is enhanced by the presence of 
Vitamin D 
 
 
Journal: Phytotherapy Research 
Manuscript ID: PTR-13-0658.R1 
Wiley - Manuscript type: Full Paper 
Date Submitted by the Author: 23-Jun-2013 
Complete List of Authors: Widaa, Amro; Royal College of Surgeons in Ireland, Department of 
Anatomy 
Brennan, Orlaith; Royal College of Surgeons in Ireland, Department of 
Anatomy 
O'Gorman, Denise; Marigot Limited,  
O'Brien, Fergal; Royal College of Surgeons, Department of Anatomy 
Keyword: 
Aquamin, Vitamin D, Osteoblast, Osteogenesis, Bone, Nutritional 
Supplements 
  
 
 
http://mc.manuscriptcentral.com/ptr
Phytotherapy Research
For Peer Review
The osteogenic potential of the marine-derived multi-mineral 
formula Aquamin is enhanced by the presence of Vitamin D 
 
 
 
Widaa, A. Ph.D1,2 
 
Tel.: +353 1 402 2530; 
E-mail address: amrowidaa@rcsi.ie 
 
Brennan, O. Ph.D1,2 
 
Tel.: +353 1 402 2147; 
E-mail address: obrennan1@rcsi.ie 
 
O’Gorman, D.M. Ph.D3 
 
Tel.: +353 1 402 8549; 
E-mail address: denise.ogorman@marigot.ie 
 
O’Brien, F.J. Ph.D1,2 (Corresponding Author) 
 
Tel.: +353 1 402 2149; 
Fax: +353 1 402 2355. 
E-mail address: fjobrien@rcsi.ie 
 
 
1. Department of Anatomy,  
Tissue Engineering Research Group (TERG), 
Advanced Materials and Bioengineering Research Centre (AMBER), 
Royal College of Surgeons in Ireland, 
123 St. Stephen’s Green,  
Dublin 2, Ireland. 
 
2. Trinity Centre for Bioengineering,  
Trinity College Dublin,  
Dublin 2, Ireland. 
 
3. Marigot Ltd.,  
Strand Farm, 
Carrigaline, 
Cork, Ireland. 
Page 1 of 24
http://mc.manuscriptcentral.com/ptr
Phytotherapy Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Keywords: Aquamin, Vitamin D3, Osteoblast, Bone, Osteogenesis, Nutritional 
Supplements 
 
 
 
Author Contributions: 
 
Widaa, A: Collection and/or assembly of data; Data analysis and interpretation; 
Manuscript Writing 
 
Brennan, O: Data analysis and interpretation; Manuscript Writing; Final approval 
of the manuscript 
 
O’Gorman, D: Provision of study material; Final approval of the manuscript 
 
O’Brien, FJ: Study design, Data analysis and interpretation, Final approval of 
the manuscript 
 
 
Page 2 of 24
http://mc.manuscriptcentral.com/ptr
Phytotherapy Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Abstract 
 
Bone degenerative diseases are on the increase globally and are often 
problematic to treat. This has led to a demand to identify supplements that aid 
bone growth and formation. Aquamin is a natural multi-mineral food 
supplement, derived from the red algae Lithothamnion species which contains 
calcium, magnesium and 72 other trace minerals. It has been previously 
reported to increase bone formation, and mineralisation. This study aimed to 
investigate the 28 day in vitro osteogenic response of Aquamin supplemented 
with Vitamin D. The osteogenic potential of MC3T3-E1 osteoblast-like cells was 
analysed in standard osteogenic medium supplemented with Aquamin +/- 
Vitamin D3, and the controls consisted of osteogenic medium, +/- Vitamin D3. 
Proliferation of osteoblasts, metabolic activity and cell viability did not differ 
between Aquamin and the osteogenic control groups. Alkaline phosphatase 
(ALP) levels and mineralisation were increased by the supplementation of 
Aquamin, and the addition of Vitamin D3 increased mineralisation for all groups. 
The combination of Aquamin and Vitamin D3 yielded a significant increase in 
ALP and mineralisation over Aquamin alone and the standard osteogenic 
control +/- Vitamin D3. This study demonstrates that Aquamin aids 
osteogenesis, and that its osteogenic response can be enhanced by combining 
Aquamin with Vitamin D3. 
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Introduction 
 
The World Health Organisation in 2000 established the ‘Bone and Joint Decade’ 
as a preventative measure to address an increase in degenerative bone 
diseases (1).  Bone is a dynamic organ and is constantly being remodelled in 
order to facilitate growth and repair. This process requires the involvement of 
osteoblast cells, which function in generating and mineralising bone giving 
strength and rigidity to the skeletal system (2). Osteoporosis is one disease 
which results from an imbalance in remodelling and is characterised by low 
bone mass, micro architectural deterioration and bone composition changes 
ultimately leading to fracture (3). Bone strength is reduced to such a degree that 
fractures can occur with minimal trauma, often involving loads no more than 
typically experienced in routine daily activity (4). Current data suggest that as 
many as 1 in 3 women and 1 in 5 men over the age of 50 are at risk of an 
osteoporotic fracture (International Osteoporosis Foundation 2013). Diet 
supplementation may assist in the prevention of osteoporosis in individuals 
whose daily mineral intake falls below that recommended by the Food and Drug 
Administration (FDA) and equivalent bodies. Although there are multiple causes 
of bone loss, two main factors that are associated with bone loss are insufficient 
calcium and Vitamin D (5). The supplementation of diets with calcium and 
Vitamin D has also been of significant interest for the prevention of fractures in 
adults in the United States (6). 
Aquamin is a commercially-available food supplement which is derived from the 
calcified skeletal remains of the red marine algae species Lithothamnion. It is 
rich in calcium as well as containing 72 other trace minerals such as 
magnesium, manganese, iron, copper and zinc (7). Aquamin has been 
identified in possessing anti-inflammatory properties by inhibiting nuclear factor 
kappa B (NFκB) signalling (8). NFκB transcription factor plays a major role in 
bone pathophysiology, resulting in osteoblast cell death, inhibition of 
proliferation, pro-inflammation and increased bone resorption cytokine signalling 
(9, 10). These anti-inflammatory properties have suggested Aquamin as 
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beneficial for the treatment of osteoarthritis, and improves clinical scores (11, 
12). Aquamin has also been shown to increase bone metabolism and 
mineralisation in yearling horses when compared with a limestone supplement 
containing equivalent levels of calcium (5). Mice which were fed a high fat 
western diet supplemented with Aquamin were found to have significantly more 
bone than mice which were not supplemented with Aquamin (6).  
A recent study from our laboratory published in Phytotherapy Research 
demonstrated that Aquamin, can increase the osteogenic potential of bone-
forming osteoblastic cells in vitro (13). We demonstrated that Aquamin 
increases alkaline phosphatase (ALP) levels, and therefore in vitro bone 
formation, and also results in higher mineralisation (13). Vitamin D has also 
been identified as playing a role in osteogenesis. Vitamin D3 readily binds to the 
osteoblast Vitamin D receptor and initiates pro-osteogenic transcription and 
subsequent osteogenesis (14, 15). Previously it has been identified that Vitamin 
D3, including different metabolit  forms, can stimulate ALP production from 
osteoblast cells (16, 17). Moreover, Vitamin D3 is known to increase in vitro 
mineralisation of osteoblasts (18). Therefore the aim of this study was, building 
on our earlier knowledge, to determine if the combination of Vitamin D3 and 
Aquamin has an additive increase on the osteogenic potential of pre-
osteoblastic cells in comparison to Aquamin alone. Furthermore we wanted to 
investigate if Aquamin, with/without Vitamin D3, has an effect on osteoblast cell 
viability after 28 days. 
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Materials and Methods  
Reagents 
All reagents were obtained from Sigma-Aldrich (Wexford, Ireland), unless stated 
otherwise. 
 
Tissue Culture Conditions 
The mouse clonal MC3T3-E1 pre-osteoblastic cell line (ATCC, Middlesex, 
United Kingdom) was used for all experiments. This is a common cell line used 
routinely for investigating osteogenesis. The cells were cultured in standard 
T175 tissue culture flasks (Sarstedt, Ireland) containing α-minimum essential 
medium (α-MEM) supplemented with 10% foetal bovine serum (FBS) (Biosera 
Ltd., United Kingdom), 2% penicillin-streptomycin solution and 1% L-glutamine. 
The cells were incubated at 37⁰C, 5% CO2 and 95% humidity. The media was 
replaced every 3–4 days, and after confluency cells were harvested using 
trypsin-EDTA and re-suspended in standard medium. MC3T3-E1 cells were 
seeded at a concentration of 5x105 cells/well in 6-well adherent plates for 24 
hours before differentiating in standard osteogenic media. MC3T3-E1 pre-
osteoblastic cells were differentiated to matrix secreting mature osteoblasts 
using the standard osteogenic cocktail over 28 days, by the supplementation of 
dexamethasone (100 nM), ascorbic acid (50 µg/ml) and β-
glycercolpentahydrate (10 mM). 
 
Preparation of Supplements  
Aquamin Soluble (Marigot Ltd., Cork, Ireland) was prepared by dissolving in 
H2O:HCL (19:1) at a final concentration of 1 mg/ml. This experimental 
concentration was chosen as optimal due to pH of the media and MC3T3-E1 
cell viability, as previously identified (13). This concentration of Aquamin 
equates to ~12 % calcium (19). The equivalent to physiological levels of 
extracellular calcium is ~0.5 mg/ml Aquamin (8). Vitamin D3 was diluted in 
100% EtOH and stored at 2-8⁰C. Final experimental concentration was adjusted 
to 5nM. 
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Statistical Analysis 
Statistical analyses were performed using a One-Way ANOVA per time point 
utilising the statistical software IBM SPSS Statistics Version 20. Data were 
represented as the mean value ± the standard error of the mean (SEM). Values 
were considered significant at P<0.05.  
 
Assessment of Cell Viability 
 
Quantification of Cell Number 
Osteoblasts were washed in warm PBS before detaching cells using a cell 
scraper. Cells were then pelleted by transferring to a tube and centrifuging at 
500g for 5 mins. Media was then removed and each pellet was re-suspended 
using 100ul of papain buffer solution [100 mL PBS, 1 mL 0.5 m EDTA 
(pH 8.0), 79 mL cysteine-HCl; 10 mg papain per 10 mL buffer] and was 
incubated at 60⁰C overnight. The following day, 30 µl of the sample was added 
to 600µl of the Hoechst buffer/working dye solution [10 mm Tris, 10 mm 
Na2EDTA, 1 m NaCl; pH 7.4 and filter sterilized with a working dye 
concentration for each experiment at 0.1 µg per mL (1:10000) dilution – 2 mL 
10× Hoechst buffer, 18 mL distilled water, 2 µl Hoechst stock dye]. Controls 
were measured as blank samples containing papain. This mixture was plated 
out at 200µl (in triplicates) in a 96 well plate. Fluorescence was read at an 
excitation of 365 nm and an emission of 485 nm (Varioskan Flash, Thermo 
Scientific). Readings were converted to cell number by standard curve.  
  
Metabolic Activity  
Non-specific metabolic activity was measured using Alamar Blue (Invitrogen, 
Biosciences, Ireland) as a colour metric assay. Media was removed from the 6 
well plates and wells were washed using PBS. A 10% solution of Alamar blue 
was made in the dark using the pre-warmed osteoblast media. Wells with 
Alamar blue but no cells were used as controls. To each well, 3mls of the 10% 
Alamar blue solution was added. The 6 well plates were returned to the 
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incubator for 2 hours at 37oC, 5%CO2 and 95% humidity following which 100µl 
(in triplicates) from each well was pipetted into a 96 well plate. The plate was 
placed into a plate reader (Varioskan Flash, Thermo Scientific) and absorbance 
was measured at wavelengths of 540nm and 620nm.  
 
Quantification of Dead Cells 
Live/Dead viability kit (Invitrogen, Biosciences, Ireland) was utilised to quantify 
the amount of dead osteoblasts. This viability assessment incorporates the use 
of Ethidium homodimer-1 (EthD-1) as a fluorescence stain, to target the nucleus 
of dead osteoblasts. At day 28 osteoblasts were examined for cell death, in 
which the positive control consisted of cells pre-treated with 100% ethanol. 
Cells were washed with warm PBS before the addition of 500 µl of an 8µM 
EthD-1 solution in PBS. The cells were then incubated with the fluorescence 
dye at 37⁰C, 5% CO2 and 95% humidity for 1 hour. The plate was then read for 
fluorescence at 530nm excitation, 645nm emission using a plate reader 
(Varioskan Flash, Thermo Scientific).  
 
Assessment of Osteogenesis  
 
Measurement of Alkaline Phosphatase Activity  
Intracellular levels of alkaline phosphatase, a well-established biochemical 
marker for bone formation, were evaluated. Osteoblast media was removed and 
cells were washed with 1 ml of warm PBS, before subsequent aspiration. 
Osteoblasts were lysed with 1 ml of lysis buffer containing a substrate for acid 
phosphatase (0.1 M Sodium acetate, 2% Triton X-100 and 10 mM para-
nitrophenol phosphate [p-npp]) and incubated in the dark for 1 hour at 37ºC. 
The reaction was stopped using 0.3 M NaOH. Triplicates (100 µl) of each well 
were then added to a 96-well plate and absorbance was then read at 405nm, 
using a microplate reader (Wallac Victor 2, Turku, Finland). 
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Von Kossa Histological Staining for Mineralisation 
Media was removed from cultured wells and cells were washed with 1 ml of 
warm PBS, before subsequent aspiration. Cells were fixed in 70% EtOH for 1 
hour at -20ºC and then washed with dH2O. Cells were stained with 5% silver 
nitrate for 60 minutes under a light source, and then washed with dH2O. 
Afterwards, 5% sodium thiosulphate was added to the wells for 2 minutes, while 
stirring the plate. Wells were washed 4 times with dH2O to remove any 
remaining unbound stain. Images were obtained using a bright field inverted 
microscope (Leica DMIL, Wetzlar, Germany) at x100 magnification, and 
recorded using a camera (Leica DFC 420C, Heerbrugg, Germany). 
 
Alizarin Red Histological Staining and Quantification for Mineralisation 
Cultured osteoblast cells were fixed as before in ice cold 70% EtOH for one 
hour and then washed with dH2O. Cells were then stained with 2% Alizarin Red 
S (pH 4.2) for 20 minutes and then washed 4 times afterwards with dH2O, as 
before, to remove residual stain. Images were obtained using a bright field 
inverted microscope (Leica DMIL, Wetzlar, Germany) at x100 magnification and 
a camera (Leica DFC 420C, Heerbrugg, Germany), as above. 
Histological staining was quantified by adding 10% cetylpyridinium to each well 
for 1 hour. Triplicates (100 µl) of each well were then added to a 96-well plate 
and absorbance was read at 540nm using a microplate reader (Varioskan 
Flash, Thermo Scientific). 
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Results 
 
The effect of Aquamin & Vitamin D on Cell Viability 
 
The effect of Aquamin +/- Vitamin D3 on osteoblast cell number was 
investigated by quantifying DNA, using the Hoechst DNA method (Fig 1A). The 
addition of Vitamin D3 to the osteogenic control or Aquamin did not affect cell 
proliferation and no differences were observed at any of the time points. All 
groups increased in cell number over 28 days and Aquamin +/- Vitamin D3 
treatment demonstrated similar proliferative levels of osteoblast cell growth 
when compared to the osteogenic control +/- Vitamin D3 (Fig 1A).  
Osteoblasts were assessed for metabolic activity which was examined by the 
Alamar Blue assay (Fig 1B). All groups demonstrated an increase in metabolic 
activity over the 28 days of culture. Aquamin produced higher levels of 
metabolic activity than the osteogenic control alone on day 7 (P<0.01), but 
resulted in similar levels over 14, 21 and 28 days (Fig 1B). The addition of 
Vitamin D3 to the osteogenic control increased the metabolic activity at day 7 
(P<0.05), 14 (P<0.05) and 21 (P<0.001) relative to the osteogenic control alone 
(Fig 1B). At day 21, the osteogenic control + Vitamin D3 resulted in the highest 
metabolic activity above all groups (Fig 1B, P<0.001) but at day 28 no 
differences were observed. The supplementation of Vitamin D3 did not increase 
metabolic activity when compared to Aquamin alone, at each of the time points 
(Fig 1B).  
Furthermore, osteoblast cell death was examined at day 28 using ethidium 
homodimer-1 as a fluorescence stain, to target the nucleus of dead osteoblasts 
(Fig 2). This investigated the effect of Aquamin and vitamin D3 on cell viability 
after 28 days of culture. Aquamin +/- Vitamin D3 treatment of osteoblasts did 
not increase cell death, when compared to the osteogenic control +/- Vitamin 
D3 (Fig 2).  
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The effect of Aquamin & Vitamin D on Osteogenesis  
 
ALP is a catalytic enzyme that is understood to play a role in mineralisation. It is 
routinely utilised as a marker of osteogenesis. ALP was normalised to 
osteoblasts cell number, in order to rule out discrepancies attributed by minimal 
differences in cell number. Aquamin alone had lower ALP levels than the 
osteogenic control at 7 days (Fig 3, P<0.05). Aquamin then demonstrated 
higher expression of ALP at 14 days (Fig 3, P<0.01) and comparable levels at 
the remaining time points when compared to the osteogenic control.  ALP levels 
did not increase with the addition of Vitamin D3 to the osteogenic control. 
However, Vitamin D3 supplementation significantly increased ALP levels over 
Aquamin alone as early as 7 days (Fig 3, P<0.0001). By day 28, Aquamin + 
Vitamin D3 displayed the highest levels of ALP when compared to Aquamin 
alone (Fig. 3, P<0.001) and the osteogenic control +/- Vitamin D3 (Fig 3, 
P<0.0001).  
Osteoblast cells produce a matrix that subsequently becomes mineralised, 
contributing to bone strength. Mineralisation was investigated by histological 
staining, followed by quantification of the mineralised stain as a direct measure 
of the degree of mineralisation. Von Kossa and Alizarin Red staining label 
mineral deposits a brown/black or red colour, respectively. Aquamin alone 
produced more mineralised nodules than the osteogenic control at day 21, 
which was further increased by day 28 (Fig 4A and Fig 4B). Nodules were 
evident at day 21 for all groups except for the osteogenic control however by 
day 28, mineralised nodules were observed in all groups. The addition of 
Vitamin D3, to Aquamin and the osteogenic control, resulted in early and visibly 
more mineralised nodules by day 21 (Fig 4A and Fig 4B). Aquamin + Vitamin 
D3 displayed the highest quantity of mineralised nodules at 21 and 28 days, 
above all groups (Fig 4A and Fig 4B).  
When mineralisation labelled by Alizarin Red was quantified, it corroborated 
these observations and demonstrated that Aquamin alone has higher 
mineralisation than the osteogenic control +/- Vitamin D3 on day 21 (Fig. 4C, 
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P<0.001) and 28 (Fig. 4C, P<0.0001).The addition of Vitamin D3 to Aquamin 
and the osteogenic control increases early mineralisation at days 7 (Fig. 4C, 
P<0.0001) and 14 (Fig. 4C, P<0.0001). Aquamin + Vitamin D3 resulted in the 
highest mineralisation at day 21 when compared to Aquamin alone (Fig. 4C, 
P<0.001) and the osteogenic control +/- Vitamin D3 (Fig 4C, P<0.0001). 
Aquamin + Vitamin D3 presented higher mineralisation than the osteogenic 
control +/- Vitamin D3 at day 28 (Fig. 4C, P<0.0001). 
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Discussion 
 
In this study, we aimed to build on existing knowledge and determine whether 
the combination of Vitamin D3 and Aquamin would enhance the osteogenic 
potential of pre-osteoblastic cells in comparison to Aquamin alone. These data 
sets demonstrated that Aquamin results in higher ALP levels and mineralisation 
over the osteogenic control, while maintaining comparable cell numbers and 
metabolic activity. The addition of Vitamin D3 to Aquamin resulted in earlier 
mineralisation and higher ALP levels, thus confirming our hypothesis and 
demonstrating the additive osteogenic effect of Vitamin D3 to Aquamin and 
adding further evidence as to the potential of Aquamin in treating bone 
disorders.  
It was not expected that Aquamin would increase osteoblast cell number, from 
our previous findings (13), and the addition of Vitamin D3 did not increase cell 
proliferation. This is most likely due to Vitamin D3’s designated primary role in 
mineralisation rather than proliferation (20). The addition of Vitamin D3 to 
osteogenic controls increased metabolism which peaked at day 21, 
corresponding with a positive staining for mineralisation. This increase in 
metabolism by Vitamin D3 was not observed with Aquamin. However, Aquamin 
resulted in early signs of cellular metabolic activity but this increase of 
metabolism was not sustained over time. We propose this may be due to the 
initial introduction of the multi-mineral formula Aquamin and an initial response 
in osteoblast metabolism as a result. The treatment of osteoblasts with Aquamin 
+/- Vitamin D3 did not affect cell viability after 28 days in culture. Previously, the 
concentration of Aquamin (1mg/ml) was determined to be the optimal dose that 
does not affect osteoblast cell viability (13), and has been used with cortical 
glial-enriched primary cells, dermal fibroblasts and colon carcinoma cell lines (7, 
19). Furthermore, Aquamin inhibits the NFκB pathway (8) which is a well-known 
inducer of cell death and inhibitor of osteogenic differentiation. The reduced 
expression of NFκB in osteoblasts results in cell survival and an increase in 
bone formation (21). 
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Vitamin D has been identified in inducing the intake of extracellular calcium 
within seconds resulting in the synthesis of the pro-osteogenic non-collagenous 
proteins, osteopontin and osteocalcin (22). Moreover a strong correlation 
between Vitamin D3 and osteocalcin, that is involved in mineralisation and 
calcium ion homeostasis, has been demonstrated for ossification in vivo (23). 
Therefore, we measured early and late markers of osteogenesis, ALP and 
mineralisation respectively. The authors chose mineralisation as the most 
important parameter for analysis as it is end point of osteogenesis. In terms of 
bone health and osteoporosis prevention and treatment, the ultimate goal is 
increased mineralisation as brittle bones are associated with diseased skeletal 
states, consequently leading to pathological fractures (24) and patient morbidity. 
ALP and mineralisation were increased when introducing Aquamin to the 
osteoblasts. This is likely due to the presence of calcium in Aquamin, which 
enhances osteoblast gene expression of bone morphogenetic proteins that are 
pro-osteogenic (25) and is a positive physiological regulator of osteoblast 
differentiation and survival (26). An additional increase in ALP and 
mineralisation was observed when supplementing Aquamin with Vitamin D3. 
Vitamin D3 binding to its receptor on osteoblasts can initiate pro-osteogenic 
events, which include an increase in ALP, mineralisation (14, 16-18) and better 
collagen quality (27). This suggests that Aquamin and Vitamin D3 complement 
each other in promoting expression of ALP and increasing mineralisation, which 
aids bone formation and strength. 
There are limitations in this study. For one, utilising alternative cell sources to 
the immortalised MC3T3-E1 murine osteoblastic cell would be interesting. In 
particular, it might be of interest to investigate the effects of Aquamin alone and 
in combination with Vitamin D3 on human primary osteoblast cells or 
mesenchymal stems cells. In addition to ALP, a more detailed analysis of gene 
expression might provide further insight into the molecular mechanisms 
influencing osteogenesis by the presence of Aquamin +/- Vitamin D3. 
Mineralisation is the final stage osteogenic marker and end point of 
osteogenesis, a more detailed analysis of osteogenic markers such as collagen 
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type-I, osteopontin and osteocalcin on the mRNA/protein level may provide a 
more comprehensive analysis into molecular mechanisms involved. In terms of 
bone health and osteoporosis prevention and treatment, the ultimate goal is 
increased mineralisation. In this study our aim was to determine whether 
mineralisation would be increased with the combination of Aquamin with 
Vitamin D3 rather than to determine its mode of action specifically. Finally, the 
effects of Aquamin and Vitamin D3 on osteogenesis should be examined in 
animal models in vivo to provide further information on the potential of the 
supplement as an anabolic agent in the fight against bone loss.  
Skeletal degenerative disease states resulting in bone loss and fractures are on 
the increase worldwide, and this can be related to an aging population and 
sedentary life style. Bone loss is associated with bone remodelling, in which the 
amount of bone being broken down (bone resorption) is less than the amount of 
bone being produced and results in a net bone loss. This leads to diseased 
states such as osteoporosis that is characterised by low bone mass and a 
failure to replace lost bone, consequently resulting in weak bones that are 
susceptible to fractures (3). Current understanding suggests that calcium and 
Vitamin D are key factors that work synergistically and are beneficial as dietary 
supplements for the prevention of bone loss and fractures (28-30). Although 
milk and dairy products offer a source of calcium, an additive non-dairy, natural 
source of calcium and other minerals is in demand.  
Aquamin is a natural food supplement that can provide a source of calcium and 
72 other minerals (7). The supplementation of Vitamin D3 to Aquamin results in 
a significant additive effect of pro-osteogenic events and therefore, may be 
beneficial when co-administered for maintaining bone health (5) and as a 
possible dietary supplement for treatment of bone loss from infectious diseases 
(24). Most treatments for osteoporosis and bone loss focus on preventing loss 
through the use of anti-resorptive agents, however, these agents only prevent 
bone loss and do not encourage new bone formation. The net result of this 
strategy is old, brittle bones that may actually be more susceptible to fracture. 
Worryingly, more and more clinical evidence is emerging which is raising clinical 
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concerns involving the long term systemic use of bisphosphonates. The current 
data suggests the potential of Aquamin in combination with Vitamin D as an 
anabolic agent in the fight against bone loss. 
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Figure 1A: Cell number was investigated over 28 days using a Hoechst DNA assay. No differences were 
observed between Aquamin +/- Vitamin D3 and the osteogenic control +/- Vitamin D3 over the 28 days. No 
increase in proliferation was observed by the addition of Vitamin D3 to each of the perspective groups. n=3. 
Figure 1B: Cell metabolic activity was determined by Alamar Blue assay over 28 days. The addition of 
Aquamin elicited an increased response in metabolic activity over the osteogenic control at day 7, and the 
addition of Vitamin D3 to the osteogenic control at day 21 above all groups respectively. Overall, Aquamin 
+/- Vitamin D3 and the osteogenic control +/- Vitamin D3 were similar in metabolic activity after 28 days. 
*P<0.001, **P<0.001, n=4.  
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Figure 2: Dead cells were quantified by fluorescence after 28 days and the positive control consisted of 
treating osteoblasts with ethanol, to induce cell death. Aquamin +/- Vitamin D3 and the osteogenic control 
+/- Vitamin D3 were comparable in the amount of dead osteoblasts, while the positive control had 
significantly higher cell death. *P<0.0001, n=4.  
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Figure 3: Normalised expression of alkaline phosphatase (ALP) levels was investigated over 28 
days.  Aquamin +/- vitamin D3 had higher levels of ALP than the osteogenic control +/- vitamin D3 on days 
14 and 28. Aquamin + vitamin D3 demonstrated the highest ALP levels on day 28, surpassing Aquamin 
alone. *P<0.05, **P<0.001, ***P<0.0001, n=4.  
180x133mm (300 x 300 DPI)  
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Figure 4A: Von Kossa histological staining which identifies mineralisation by a brown/black stain was 
examined over 28 days. Aquamin +/- vitamin D3 displayed more mineralised nodules than the osteogenic 
control +/- vitamin D3 on days 21 and 28. Aquamin + vitamin D3 demonstrated the highest quantity of 
mineralised nodules on day 28. n=4.  
Figure 4B: Alizarin Red histological staining which identifies mineralisation by a red stain was examined 
over 28 days.  Aquamin +/- vitamin D3 displayed more mineralised nodules than the osteogenic control +/- 
vitamin D3 on days 21 and 28. Aquamin + vitamin D3 demonstrated the highest quantity of mineralised 
nodules on day 28, outperforming Aquamin alone.  n=4.  
Figure 4C: Alizarin Red histological staining (Fig 2B) was quantified by removing the absorbed red stain and 
reading absorbance at 540 nm. Vitamin D3 resulted in early mineralisation for both Aquamin and the 
osteogenic control at days 7 and 14. Aquamin +/- vitamin D3 displayed higher levels of mineralisation than 
the osteogenic control +/- vitamin D3 on days 21 and 28. Aquamin + vitamin D3 demonstrated the highest 
levels of mineralisation on day 21, above all treated groups.  *P<0.001, **P<0.0001, n=4.  
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